Product Program year 2019 Source: CMS Open Payments

General Hysteroscopic Biopsy

Device General

Open in the dashboard

General payments

$21,766

62 payments

Research payments

$0

0 payments

Through program year 2019, $21,766 in general payments and $0 in research payments were reported against General Hysteroscopic Biopsy (General).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $21,766 62

Breakdown

Who paid General payments · program year 2019
  1. Boston Scientific Corporation $21,766 62 payments
Top recipients General payments · program year 2019
  1. Teresa Darragh Cytopathology · San Francisco, CA $6,512 30% · 2 payments
  2. Bruce Kahn Urogynecology and Reconstructive Pelvic Surgery · La Jolla, CA $5,334 25% · 3 payments
  3. Judith Volkar Obstetrics & Gynecology · Pittsburgh, PA $4,360 20% · 4 payments
  4. Britt Erickson Gynecologic Oncology · Minneapolis, MN $3,867 18% · 1 payment
  5. Harvey Winkler Urogynecology and Reconstructive Pelvic Surgery · Great Neck, NY $121 <1% · 1 payment

The top 5 of 53 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Cytopathology Pathology $6,512 30% · 1 practitioner
  2. Obstetrics & Gynecology $5,663 26% · 41 practitioners
  3. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $5,533 26% · 3 practitioners
  4. Gynecologic Oncology Obstetrics & Gynecology $3,867 18% · 1 practitioner
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $29 <1% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $11,858 54% · 3 recipients
  2. Pennsylvania $4,360 20% · 1 recipient
  3. Minnesota $3,867 18% · 1 recipient
  4. Illinois $489 2% · 20 recipients
  5. New York $485 2% · 4 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

62 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record